Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Packpharm Limited
FDA Inspection
•Packpharm Limited•September 1, 2023

Packpharm Limited – FDA Inspection, Sep 1, 2023

Record Details

This FDA Inspection record concerns Packpharm Limited, with an inspection on September 1, 2023, issued by the Office of Inspections and Investigations.

Company
Packpharm Limited
Inspection Date
September 1, 2023
Office
Office of Inspections and Investigations
Person
  • Saleem A. Akhtar
View Company Profile

ID · 9ec1b1f6-2812-44ee-b86e-14f845ee9f7b

Inspection Facts

Inspection number
1218081
FDA center
Human Drugs
Outcome
Form 483 issued

Other FDA inspections of Packpharm Limited

1
DateClassificationOfficeProject area
March 31, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Packpharm Limited
  • FDA Inspection 1252290 - 2023-03-31

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Packpharm Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.